New Report Offering Insightful Analysis on Lampalizumab-Launch - 2017
Over the years, various affective drugs have come up for preventing neovascular age-related macular degeneration (nAMD). However, medical researchers and pharmaceutical companies are yet to achieve any significant success in finding an effective treatment for geographic atrophy (GA), which is the late-stage atrophic form of dry age-related macular degeneration (dAMD). This is where lampalizumab becomes an exciting prospect, as it shows promising signs of becoming the first drug treatment for dAMD condition. Market Research Hub (MRH) has recently announced the...
View full press release